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Abstract
Background: P. aeruginosa is one of the top three causes of opportunistic human bacterial infections. The remarkable
variability in the clinical outcomes of this infection is thought to be associated with genetic predisposition. However,
the genes underlying host susceptibility to P. aeruginosa infection are still largely unknown.
Results: As a step towards mapping these genes, we applied a genome wide linkage analysis approach to a mouse
model. A large F2 intercross population, obtained by mating P. aeruginosa-resistant C3H/HeOuJ, and susceptible A/J
mice, was used for quantitative trait locus (QTL) mapping. The F2 progenies were challenged with a P. aeruginosa
clinical strain and monitored for the survival time up to 7 days post-infection, as a disease phenotype associated trait.
Selected phenotypic extremes of the F2 distribution were genotyped with high-density single nucleotide polymorphic
(SNP) markers, and subsequently QTL analysis was performed. A significant locus was mapped on chromosome 6 and
was named P. aeruginosa infection resistance locus 1 (Pairl1). The most promising candidate genes, including Dok1,
Tacr1, Cd207, Clec4f, Gp9, Gata2, Foxp1, are related to pathogen sensing, neutrophils and macrophages recruitment and
inflammatory processes.
Conclusions: We propose a set of genes involved in the pathogenesis of P. aeruginosa infection that may be explored
to complement human studies.
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Background
P. aeruginosa is a versatile Gram-negative bacterium
mainly implicated in pneumonia in intensive care settings
and in patients with neutropenia, advanced AIDS,
bronchiectasis, hereditary cystic fibrosis (CF) disease and
advanced chronic obstructive pulmonary disease (COPD).
Hospital-acquired pneumonia (HAP) occurs predomin-
antly in patients with intubation and mechanical ventila-
tion in an intensive care unit (ICU) [1, 2]. The risk of
fatality in these patients is generally high but variable even
with the correct use of antibiotics. Similarly to other
infectious agents, exposure to P. aeruginosa results in a
range of mild to severe clinical symptoms which can lead
to fatal bacteremia in critically ill patients [3].
In general, the pathophysiology of human infections is
a complex and dynamic process that depends on several
factors: the genetic predisposition, the co-morbid condi-
tions, the host immune response, the type of pathogen,
and the site and extent of infection [4]. Most of the
studies in the field of P. aeruginosa have been concen-
trated on the type of strains and the virulence factors
[5–10]. A major contributing cause of P. aeruginosa
predominance and pathogenesis was attributed to its
ability to adapt to many different environments and
cause a wide range of diseases in humans [11]. Less
attention has been paid to host genetic predisposition as
a contributing factor to the clinical outcome of P.
* Correspondence: bragonzi.alessandra@hsr.it
Maura De Simone and Lorenza Spagnuolo: These authors have equal
contributions and share first authorship.
Fuad A. Iraqi and Alessandra Bragonzi: These authors have equal
contributions and share senior authorship.
†Equal contributors
1Infection and Cystic Fibrosis Unit, IRCCS San Raffaele Scientific Institute,
Milan, Italy
Full list of author information is available at the end of the article
© 2016 De Simone et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
De Simone et al. BMC Genomics  (2016) 17:351 
DOI 10.1186/s12864-016-2676-4
aeruginosa infection. However, evidence of genetic
predisposition is emerging in the CF and COPD popula-
tions. In CF, it has been shown that the progression and
severity of pulmonary disease do not appear to correlate
exclusively with specific mutations in the causative gene
cystic fibrosis transmembrane conductance regulator
(CFTR) but appear to be largely dependent on other
modifier genes [12, 13]. In COPD, several host candidate
genes have been proposed as causing the acceleration of
lung function decline but have never been associated
with P. aeruginosa infection [14, 15]. Regarding other
patients at risk of P. aeruginosa infection, no study has
yet been reported. The size of cohorts, strong but often
unknown environmental influences, poor diagnosis, and
lack of repeatability limit scientific advancements in
understanding the genetic basis of susceptibility to P.
aeruginosa diseases in humans.
Inbred mice, with defined and reproducible genetics,
can be maintained in standardized environments and
exposed to identical challenges, unlike human popula-
tions. These aspects allow us to directly correlate the
phenotypic response to the specific genotype. Inbred
mice have been successfully adopted to allow us to
understand the genetic basis of differential susceptibility
to infections (e.g. bacteria, viruses and parasites) [16, 17].
When genes are identified in a mouse model, human
orthologue genes can subsequently be identified. In the
context of P. aeruginosa infection, variability in survival,
magnitude of inflammatory response, bacterial clearance
and lung damage have been reported in various inbred
strains [18–22]. Recently, we also showed that the
genetic background of the host influences the re-
sponse to P. aeruginosa infection [23]. These data
were obtained by ranking nine inbred murine strains
characterized by a wealth of genetic and phenotypic
diversity. In particular, A/J and C3H/HeOuJ showed
the most deviant clinical (e.g. body weight and mor-
tality) and immunological phenotypes (e.g. cytokines
and innate immune cells response). These results
provided a basis for mapping genomic regions under-
lying host susceptibility to P. aeruginosa infection.
Among different traits recorded, mortality caused by
bacteremia was considered as the ultimate clinical
expression of the deleterious clash between the host
immune response and invasive microorganisms. Con-
sequently, in this study we generated an informative
F2 population by crossing between the parental
strains, including resistant C3H/HeOuJ and suscep-
tible A/J mice and subsequently performed quantita-
tive trait loci (QTLs) mapping analysis. We identified
a genetic locus on murine chromosome 6, designated
P. aeruginosa infection resistance locus 1 (Pairl1),
that has major effect on the susceptibility to P.
aeruginosa infection and risk of bacteremia.
Methods
Ethic statement
Animal studies were conducted according to protocols
approved by San Raffaele Scientific Institute (Milan,
Italy) Institutional Animal Care and Use Committee
(IACUC) and adhered strictly to the Italian Ministry of
Health guidelines for the use and care of experimental
animals (Permit number: 502). Research on the bacterial
isolates AA2, from the individual with CF, used for
animal experiments, has been approved by the Ethics
Commission of Hannover Medical School, Germany.
The patients and parents gave informed verbal consent
before the sample collection. Approval for storing of
biological materials was obtained by the Ethics Commis-
sion of Hannover Medical School, Germany.
Bacterial strain
P. aeruginosa clinical isolate AA2 was described before
[6, 23, 24]. The strain was cultured in trypticase soy
broth (TSB) and plated on trypticase soy agar (TSA).
Mice, breeding and P. aeruginosa lung infection
Based on our previous study, we have determined that
A/J and C3H/HeOuJ are susceptible and resistant to P.
aeruginosa infection [23], respectively 7–8 weeks old
male and female mice of A/J and C3H/HeOuJ were
purchased from Jackson Laboratory, and used as the
parental founders of F2 mapping population. An
outcross between the two founders was conducted and
subsequently the members of the first generation (F1
population) were intercrossed to generate 400 (A/J X C3H/
HeOuJ) F2 mice. A/J, (n = 22) C3H/HeOuJ (n = 26), and
(A/J x C3H/HeOuJ) F2 mice (n = 400) were intratracheal
injected with a dose of 5 × 106 of the planktonic P. aerugi-
nosa clinical isolate AA2, and monitored for survival up to
7 days according with established procedures [23].
Mice were maintained in pathogen free conditions
during breeding and transferred in biosafety level 3 sta-
bulary for infection experiments. Mice were observed
daily for clinical signs including coat quality, posture,
ambulation, and hydration status.
Statistical significance by Mantel-Cox test was performed
to compare the survival between pairs. The data are pooled
at least from three independent experiments.
Genotyping
We applied a selective genotyping approach, as suggested
by Darvasi and Soller [25], whose power was successfully
proven and confirmed in several previous studies [26–30].
We genotyped only the phenotypic extremes of the entire
F2 outcross population. A total of 160 mice of the F2
population (20 % of highly and 20 % lowly susceptible)
were genotyped and genotypes were randomized by
meiosis.
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High molecular genomic DNA samples of the 160 F2
mice and the parental mouse strains were extracted from
tail biopsies with the DNeasy Blood and Tissue (Qiagen,
Hilden, Germany). Samples were analyzed for purity
(A260/A280) and DNA content was evaluated by Nano-
Drop measurement. The genomic DNA samples of the F2
progeny were genotyped with MegaMUGA mouse array
which consists 77,000 SNP markers based on the
Illumina® Infinium platform [31]. The SNP genotype was
conducted at Neogen company (Neogen/Geneseek,
Lincoln, NE, USA). The SNP markers are distributed across
the entire genome with an average spacing of 33 Kb.
QTL analysis
To map QTL contributing to survival, we used Haley-
Knott regression [32], including sex as an additive covariate
(that is, allowing for a shift in average survival between the
two sexes, but assuming that the effect of a QTL is the
same in both sexes). Statistical significance was assessed by
a permutation test [33], correcting for the multiple
statistical tests inherent in the scan of the genome.
Sample size was chosen to give 80 % power to detect
a QTL explaining ~5 % of the phenotypic variance. A
confidence interval for the location of the inferred
QTL was derived as a 1.5-LOD support interval [34].
Calculations were performed with R/qtl [35], an add-on
package to the general statistical software R (R Develop-
ment Core Team 2015).
Candidate genes analysis
The public database Mouse Genome Informatics (MGI,
http://www.informatics.jax.org/) was used for the identi-
fication of suggested genes within the QTL interval and
for prioritization together with Endeavour [36, 37]. To
generate the training sets of genes employed for the ana-
lysis, we used the ‘key word’ approach described previ-
ously [38, 39].
Statistical analysis
We used Mantel-Cox test to compare the survival
between pairs. Tests were considered statistically signifi-
cant when the significance level was ≤ 0.05.
Results
Susceptibility to P. aeruginosa pulmonary infection in
(A/JxC3H/HeOuJ) F2 progenies
Our experiments established that the intratracheal injec-
tion of 5 × 106 CFU of the P. aeruginosa clinical isolate
AA2 causes the death of A/J mice within 24 h, whereas
a set of C3H/HeOuJ mice (~40 %) survives for more
than 7 days (Fig. 1). The selected A/J and C3H/HeOuJ
parental inbred mouse strains were highly and signifi-
cantly divergent in the risk of sepsis (p < 0.0001, Mantel-
Cox test). To analyse the potential contribution of genetic
factors to P. aeruginosa infection, the F1 population and
subsequently 400 (A/JxC3H/HeOuJ) F2 mice were gener-
ated by reciprocal mating of susceptible A/J and resistant
C3H/HeOuJ mice. The entire F2 population was infected
with P. aeruginosa as described above and survival of each
mouse was recorded over a period of 7 days post-
infection. F2 progenies showed a survival which was
significantly higher than the susceptible strain A/J, but
lower when compared to C3H/HeOuJ parental lines
(Fig. 1). Then, to collect data for the subsequent genome
analysis, the F2 population was sorted based on the
phenotypic extremes - the most susceptible (F2-S) (20 %
of F2 population n = 80) and most resistant (F2-R) (20 %
of F2 population n = 80) -. The selected F2-S showed a
significantly lower survival compared to C3H/HeOuJ mice
(Hazard Ratio 0.03057, 95 % CI 0.01386 to 0.06741;
p < 0.0001, Mantel-Cox test) but similar to A/J mice
(Hazard Ratio 0.4345, 95 % CI 0.1288 to 1.466) while
F2-R showed a significantly higher survival compared
to the parental C3H/HeOuJ (Hazard Ratio 2.969,
95 % CI 1.382 to 6.378; p = 0.0053, Mantel-Cox test)
and A/J mice (Hazard Ratio 688.9, 95 % CI210.3 to
2256; p < 0.0001,Mantel-Cox test). The rest of the F2
population (Fig. 1 as not detected genotype, F2-nd)
showed survival kinetics that were significantly different
from F2-S and F2 -R (Hazard ratio 0.004038, 95 % CI
0.002248 to 0.007256 for F2-S, and Hazard ratio
18.56,95 % CI 12.65 to 27.21 for F2-R; p < 0.0001, Mantel-
Cox test) and the parental lines (Hazard Ratio 0.3129,
95 % CI 0.1486 to 0.6589 for C3H/HeOuJ; p = 0.0022
Mantel-Cox test, and Hazard Ratio 5785, 95 % CI 1549 to
21606 for A/J;p < 0.0001, Mantel-Cox test). Finally the en-
tire F2 population (n = 400) showed a significantly higher
survival compared to the parental A/J (Hazard Ratio
Fig. 1 Survival curves of A/J, C3H/HeOuJ and (AJ x C3H/HeOuJ) F2
population after acute P. aeruginosa lung infection. A/J (n = 22),
C3H/HeOuJ (n = 26), and (A/J x C3H/HeOuJ) F2 mice (F2 complete
population n = 400; F2-S: 20 % most susceptible genotyped, n = 80;
F2-R: 20 % most resistant genotyped, n = 80; F2-nd not detected
genotype, n = 240) were intratracheal injected with a dose of 5 × 106
of the planktonic P. aeruginosa clinical isolate AA2, and monitored
for survival up to 168 h (7 days). Statistical significance by Mantel-Cox
test is reported in Additional file 1
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49.79, 95 % CI 19.16 to 129.4;p < 0.0001, Mantel- Cox test)
a slightly significantly lower survival when compared to
the parental C3H/HeOuJ (Hazard Ratio 0.5007, 95 % CI
0.3270 to 0.8615; p = 0.0104 Mantel- Cox test). The
complete statistical analysis is reported in Additional file 1
(Table S1). The distribution histogram of the survival time
in the F2 population, with values ranging from 0,5 to
7 days, is shown in Fig. 2b, along with the distribution in
A/J mice (Fig. 2a) and C3H/HeOuJ mice (Fig. 2c).
Additional analysis showed that high numbers of CFUs
(average of 1 × 106 in the whole spleen) were present in
the moribund mice, both parental and their progenies,
indicating sepsis as the cause of death (data not shown).
Mapping the genetic determinants to P. aeruginosa
susceptibility
In the next phase, we proceeded to map the genetic
factors that contributed to susceptibility to the P. aerugi-
nosa acute lung infection. The survival time was used as
the main phenotypic trait for mapping QTL associated
with host susceptibility to this opportunistic pathogen.
In order to maximize the ability to detect the QTLs, we
took advantage of the selective genotyping approach,
described previously [25] and successfully applied in
several studies [27–29]. The phenotypic extremes F2-S
and F2-R were genotyped with about 10 K informative
SNP markers selected from MegaMuga SNP array, and
subsequently QTL mapping was performed. We identi-
fied a significant QTL on chromosome 6 (p = 0.037) at
map position 90.8 Mbp with LOD Score = 4.3, and with
a 1.5-LOD support genomic interval of 81.5–102.2 Mbp
(Fig. 3). The SNPs markers used to genotype the locus
of interest on chromosome 6 are reported in Additional
file 2 (Table S2). We defined the mapped QTL on
chromosome 6 as Pairl1 for P. aeruginosa infection re-
sistance locus 1.
The effect of the locus on survival is presented in
Additional file 3 (Figure S1). The locus shows some
degree of over-dominance, with the heterozygotes sur-
viving longer than the homozygotes (A/J homozygotes
versus heterozygotes p = 0.0056 Mantel-Cox test; C3H/
HeOuJ homozygotes versus heterozygotes p < 0.0001,
Mantel-Cox test) and a transgressive allele segregation
with the A/J homozygotes surviving longer than the C3H/
HeOuJ homozygotes. This is the opposite what would be
expected from the parental strains’ phenotypes.
Identification and functional classification of candidate genes
A total of 323 genes within the Pairl1 interval were identi-
fied from the public database (http://informatics.jax.org/),
as described in Material and methods and classified as
protein coding genes (n = 198), RNA genes (n = 50), un-
classified genes (n = 45) and unclassified non-coding RNA
genes (n = 30). The full list of genes in the interval is re-
ported in Additional file 4 (Table S3). Gene prioritization
was: i) carried out by integrative computational analysis of
public and private genomic data [38], ii) based on training
lists of genes involved in relevant biological and
pathological processes and iii) ranked based on litera-
ture research.
To prioritize our genes, we used Endeavour and the
MGI database (http://informatics.jax.org/). For Endeav-
our, candidates genes are first ranked according to their
similarity to a list of known disease training genes
involved in lung infection, bacteremia, pneumonia, sep-
sis, chemotaxis, P. aeruginosa, innate immune response,
pattern recognition receptor, neutrophils, complement,
CF, modifier genes in CF, and COPD (Additional file 5A:
Table S4A). For the MGI database, we based the search
on different keywords (Lung, Infection, Respiratory AND
Infection) and gene ontology terms (Immune AND
Response, Cytokines, Chemotaxis) (Additional file 5B:
Table S4B). Interestingly, the two different approaches
Fig. 2 Histograms of survival time of A/J, C3H/HeOuJ and (AJxC3H/
HeOuJ) F2 population after acute P. aeruginosa lung infection. a A/J
(n = 22), b C3H/HeOuJ (n = 26), and c (A/J x C3H/HeOuJ) F2 mice
(n = 400) were intratracheal injected with a dose of 5 × 106 of the
planktonic P. aeruginosa clinical isolate AA2, and monitored for
survival up to 7 days
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revealed several redundant genes and consequently, we
proceeded with a systematic literature research to confirm
a possible role in susceptibility to P. aeruginosa infection.
The candidate genes in Table 1 are those revealed by the
literature research as having a putative role in host defense
to infection. In particular, the most promising candidate
genes (Dok1, Tacr1, Cd207, Clec4f, Gp9, Gata2, Foxp1)
were those involved in pathogen sensing, neutrophils and
macrophages recruitment, and inflammatory process. Our
prioritization of results depends on the adopted criteria for
the bioinformatics analysis and on the bioinformatics tool
itself. Therefore, it cannot be excluded that other possible
candidate genes present in our list could somehow play a
role in P. aeruginosa infection.
Discussion
Phenotypic variations of host response to P. aeruginosa
infection have been demonstrated in several inbred mouse
strains [18–22] and in the most recent Collaborative Cross
population [40 ]. In our earlier work, we showed that
classical inbred strains of mice manifest an extreme
response - highly resistant or highly susceptible - to P.
aeruginosa infection [23]. In particular, the risk of fatality
in A/J mice was high after exposure to P. aeruginosa while
C3H/HeOuJ showed milder clinical symptoms associated
to higher resolution of the infection. However, the genetic
component of this trait is still poorly understood. For the
first time to our knowledge, in this study, we localized a
genetic determinant of susceptibility to P. aeruginosa
respiratory infection. First, we generated an informative
F2 population by crossing the resistant C3H/HeOuJ and
susceptible A/J mice. Next, we scored this F2 population
for survival time, as the main associated disease pheno-
typic trait, and subsequently used it for QTL mapping.
The P. aeruginosa dose for infection of the newly gener-
ated populations was selected according to the most
deviant differences in survival between parental lines. The
F2 population showed a wide range of responses in terms
of survival compared to the parental lines. For this study,
we used P. aeruginosa isolate sampled at the onset of
infection from a CF patient and fully characterized in pre-
vious studies [41–44 ]. Although the P. aeruginosa strain
Fig. 3 QTL scan showing LOD score (Y-axis) and genome position (X-axis) for susceptibility to P. aeruginosa infection. The x axis shows chromosome
numbers, the y axis shows the statistical significance of the association measured as LOD, logarithm of the odds favouring linkage, a score that
measures the strength of evidence for the presence of a QTL among the 160 mice of the F2 population, including F2-S and F2-R. The horizontal line is
plotted at the 5 % significance threshold. One significant QTL (p = 0.037) named Pairl 1 was mapped on chromosome 6 at 90.8 Mbp with 4.3 LOD
score, with a 1.5-LOD drop support interval of 81.5–102.2 Mbp
Table 1 The list of the most promising candidate genes
identified in the Pairl1 locus
Gene name Biological function References
Dok1 Adaptor protein involved in:
• lung homeostasis
• negative regulation of LPS signaling
• Downregulation of its expression in in vitro
models
[28, 29]
Tacr1 Receptor for neuropeptide tachykinin involved in:
• Cytokines and chemokines expression
• Chemotaxis and neutrophils activation
• P. aeruginosa corneal infection
[30–32]
Cd207
Clecf4
Members of C-type lectin superfamily involved in:
• Pathogen sensing of virus, fungi and bacteria
[33–35]
Gp9 Glycoprotein 9-Glycoprotein Ib complex
involved in:
• Leukocytes migration
• Inflammation
• Neutrophils extracellular trap formation
[36]
Foxp1
Gata2
Transcriptional factors involved in:
• Cytokines expression
[37, 38]
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was selected on the basis of its similarity to environmental
strains, including genotypic and phenotypic features, it is
possible that this particular strain may affect several
physiological parameters and subsequent analysis.
Our genetic linkage approach was successful in identi-
fying for the first time the Pairl1 locus, on murine
chromosome 6, linked to susceptibility to P. aeruginosa
pulmonary infection with a genome wide significance of
95 % (p < 0.05). Here, the gene prioritization approach
was used to rank genes involved in the susceptibility to
P. aeruginosa infection. This approach was applied
successfully in candidate gene analysis in other diseases
such as obesity, Type 2 diabetes, and asthma [45, 46 ].
The most promising candidate genes included in the
Pairl1 locus, namely Dok1, Tacr1, Cd207, Clec4f, Gp9,
Gata2 and Foxp1, are mainly involved in pathogen sensing,
neutrophils recruitment and cytokines response.
In more detail, as Dok1 (Docking protein1) belongs to
a family of adaptor proteins, it plays a critical anti-
inflammatory role in lung homeostasis. It is involved in
negative regulation of LPS signaling and its expression is
downregulated after P. aeruginosa infection in vitro
[47, 48]. Together with Dok 2 and Dok 3, it plays
essential roles in negative regulation of a wide variety
of signaling pathways in both innate and adaptive immun-
ities [49]. Mice knock-out for Dok1 were hypersensitive to
LPS showing high levels of TNFα and NO [48] while triple
KO mice (Dok1-2-3) showed spontaneous pulmonary
inflammation, with hallmarks of asthma, including eosino-
philia, goblet cell hyperplasia, and subepithelial fibrosis
[50]. Most importantly, downregulation of Dok1 gene
expression in human alveolar macrophages after P. aerugi-
nosa infection in vitro, indicates its direct involvement in
this bacterial infection [48].
The gene Tacr1 (Tachykinin receptor 1) encodes the re-
ceptor for the neuropeptide tachykinin and is implicated
in mediating a variety of proinflammatory processes,
including upregulation of cytokine and chemokine
expression, chemotaxis and activation of inflammatory
cells, all pathways that seem to be altered in susceptible
A/J mice during acute P. aeruginosa infection [51].
Moreover, the binding of this receptor with its ligand has
been shown to increase the neutrophils adhesion to bron-
chial epithelial cells [52]. More interestingly, Tacr1 has
been implicated in several bacterial infections and in sep-
sis [53, 54], including P. aeruginosa corneal infection [55].
Cd207 (C-type lectin domain family 4 member K) gene
encodes a type II transmembrane, C-type lectin receptor
displaying mannose-binding specificity. It has high affinity
for mannose structures abundantly expressed by patho-
gens, especially by viruses (HIV-1 and HSV) as well as the
mycobacterial cell wall component mannosylated lipoara-
binomannan (ManLAM) and pathogenic funguses such as
Candida species, Malassezia furfur and Saccharomyces
cerevisiae [56]. The gene Clec4f shows high similarity with
Cd207, and therefore might be involved in the same
processes. The importance of these genes in the context
of P. aeruginosa infection might be seen in the functional
association of this C-type lectin receptor with the
Mannose Binding Lectin 2 (MBL2) gene, which codes for
the MBL, a well-known modifier gene in CF. In fact, poly-
morphisms in MBL2 are associated with differing level of
MBL production, and deficiencies in MBL production
have been linked to an increased incidence of infection,
[57]. In particular it predisposes to early infection with
P. aeruginosa which in turn, leads to more severe lung
disease [58].
Interestingly, other candidates in the Pairl1 locus play
important roles in leukocytes recruitment. Specifically,
Gp9 (glycoprotein 9), expressed by platelets, is involved
in leukocyte migration, inflammation and promotion of
neutrophil extracellular trap formation [59]. In a mouse
model of sepsis this glycoprotein complex contributes to
a platelet/neutrophil and platelet/monocyte axis with
significant consequences to the innate immune response
in terms of elevated serum cytokine levels and Mac1
increased expression by neutrophils for their extracellu-
lar cell migration. Among the candidate genes, we also
identified the transcription factors Foxp1 (Forkhead box
P1) and Gata2 (GATA binding protein 2) that are
involved in pro-inflammatory cytokines expression, such
as IL1ß, IL-6 and IL-17RA correlated to the Th17
pathway (http://www.innatedb.com/) [60].
Conclusions
We suggest promising candidates for the genetic basis of
host susceptibility to P. aeruginosa infection. In addition
to a better understanding of host pathogen interactions,
the characterization of these genes may have significant
implications for the discovery of novel possible thera-
peutic targets and/or prognostic biomarkers complement-
ing human studies.
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